[go: up one dir, main page]

WO2008147169A3 - Microemolsion conteniendo pirfenidona - Google Patents

Microemolsion conteniendo pirfenidona Download PDF

Info

Publication number
WO2008147169A3
WO2008147169A3 PCT/MX2008/000068 MX2008000068W WO2008147169A3 WO 2008147169 A3 WO2008147169 A3 WO 2008147169A3 MX 2008000068 W MX2008000068 W MX 2008000068W WO 2008147169 A3 WO2008147169 A3 WO 2008147169A3
Authority
WO
WIPO (PCT)
Prior art keywords
microemulsion containing
containing pirfenidone
pirfenidone
microemulsion
capsules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MX2008/000068
Other languages
English (en)
French (fr)
Other versions
WO2008147169A2 (es
WO2008147169A8 (es
Inventor
Castro Jose Agustin Rogelio Magana
Borunda Juan Socorro Armendariz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008147169A2 publication Critical patent/WO2008147169A2/es
Publication of WO2008147169A3 publication Critical patent/WO2008147169A3/es
Publication of WO2008147169A8 publication Critical patent/WO2008147169A8/es
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención describe una composición microemulsionable de Pirfenidona, que ofrece ventajas sobre otras formas farmacéuticas de administración oral conocidas en el estado de la técnica, como son tabletas, cápsulas, suspensiones y soluciones.
PCT/MX2008/000068 2007-05-29 2008-05-29 Microemolsion conteniendo pirfenidona Ceased WO2008147169A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXMX/A/2007/006348 2007-05-29
MX2007006438 2007-05-29

Publications (3)

Publication Number Publication Date
WO2008147169A2 WO2008147169A2 (es) 2008-12-04
WO2008147169A3 true WO2008147169A3 (es) 2009-01-22
WO2008147169A8 WO2008147169A8 (es) 2009-07-30

Family

ID=40075678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2008/000068 Ceased WO2008147169A2 (es) 2007-05-29 2008-05-29 Microemolsion conteniendo pirfenidona

Country Status (1)

Country Link
WO (1) WO2008147169A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2567283T3 (es) 2008-06-03 2016-04-21 Intermune, Inc. Compuestos y métodos para tratar trastornos inflamatorios y fibróticos
CN102846555B (zh) * 2012-04-09 2014-06-25 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
CA2943363A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016775A1 (en) * 1998-09-18 2000-03-30 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
WO2004058256A1 (en) * 2002-12-26 2004-07-15 Kdl, Inc. Pharmaceutical liquid composition containing pyridone derivative
US20060039931A1 (en) * 2002-09-13 2006-02-23 Mepha Ag Stable cream preparations of phenyl-pyridone compounds for topical application
WO2007038315A2 (en) * 2005-09-22 2007-04-05 Intermune, Inc. Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000016775A1 (en) * 1998-09-18 2000-03-30 Mepha Ag Topical formulation of alkyl-, phenyl-pyridone
US20060039931A1 (en) * 2002-09-13 2006-02-23 Mepha Ag Stable cream preparations of phenyl-pyridone compounds for topical application
WO2004058256A1 (en) * 2002-12-26 2004-07-15 Kdl, Inc. Pharmaceutical liquid composition containing pyridone derivative
WO2007038315A2 (en) * 2005-09-22 2007-04-05 Intermune, Inc. Capsule formulation of pirfenidone and pharmaceutically acceptable excipients

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GARCIA SANCHEZ M.J. ET AL.: "Monografias Galenicas, Formas orales solidas (I)", LABORATORIOS GLAXO, 1993, pages 22 - 30 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359379B2 (en) 2012-10-02 2016-06-07 Intermune, Inc. Anti-fibrotic pyridinones

Also Published As

Publication number Publication date
WO2008147169A2 (es) 2008-12-04
WO2008147169A8 (es) 2009-07-30

Similar Documents

Publication Publication Date Title
WO2008037716A3 (en) Pharmaceutical compositions comprising nilotinib or its salt
WO2007052289A3 (en) Novel dispersible tablet composition
WO2010066749A3 (en) Ulipristal acetate tablets
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
WO2007090393A3 (de) Pharmazeutische zubereitung auf basis vom mikrotabletten
JP2009537554A5 (es)
WO2009081174A3 (en) Anti - retroviral combination
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
WO2010049449A3 (en) Novel salts of sunitinib
WO2008093838A1 (ja) スルファモイル基を有するピリジルイミダゾリジン誘導体、およびその医薬としての使用
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
WO2008147169A8 (es) Microemolsion conteniendo pirfenidona
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2007072061A3 (en) Crystalline pyrimidine nucleoside derivatives suspensions in capsules
WO2009013594A3 (en) Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process
WO2008059298A3 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
WO2006122777A3 (de) Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
WO2009110010A3 (en) Oral dosage form comprising amlodipine and olmesartan
WO2009049961A3 (en) New no-donor aspirin derivatives
PL1589014T3 (pl) Sposób syntezy pochodnych 1,3-dihydro-2H-3-benzazepin-2-onu i jego zastosowanie do wytwarzania iwabradyny i jej dopuszczalnych farmaceutycznie soli
WO2007144699A3 (en) Process for the preparation of alfuzosin
WO2006012779A8 (en) Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical
WO2009056617A3 (en) 4,4-disubstituted piperdines as renin inhibitors

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2